MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Industry news

News of the day

NUVO RESEARCH PROVIDES WF10 LICENSING AND DEVELOPMENT UPDATE

Mississauga, Ontario, Canada - November 11, 2009 - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be... more

Mobidiag Launches Rapid DNA Microarray Technology for Diagnostics of Bone and Joint Infections

Birmingham, United Kingdom, November 11, 2009 - Finnish molecular diagnostics company Mobidiag releases rapid microarray solution for identifying bacteria responsible for bone and joint infections (BJIs). Enhancing the test panel with targets such as Kingella kingae and Propionibacterium acnes adds new capabilities to Mobidiag's assay. Prove-it(TM) Sepsis application for Bone and Joint infections includes simultaneous identification of altogether 64 bacterial targets in a single assay thus... more

Foamix Extends Collaboration with Galderma

Rehovot (Israel), November 3, 2009 -- Foamix Ltd, a global leader in the development of dermatological foam medications today announced that the company has extended its agreement with Galderma to develop an innovative medicated foam for an additional dermatological indication. This new treatment contains a novel drug for the therapy of certain skin diseases. more

Industry news search

Search the Pharmalicensing Industry news by keyword. Alternatively our advanced search allows you to query by category and therapeutic target.
 
Category Therapeutic target
 
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Recent news

To keep up to date with news from this category use our RSS Feed to keep up to date

XOFT SHOWCASES MULTI-DISCIPLINARY ELECTRONIC BRACHYTHERAPY CANCER TREATMENT PLATFORM AT ASTRO
CHICAGO, Nov. 2, 2009 - Xoft, Inc., developer of the Axxent

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us